Characterization of the Maternally Derived Antibody Immunity against Rhdv-2
Publikasi
Kelinci
Muncul di
MDPI Vaccines, 2020
The aim of this study was to test whether an inactivated vaccine indicated for active immunization of adult rabbits can produce a passive antibody immunity in blood against RHDV-2 in rabbit kits.
The present study demonstrated that an inactivated vaccine designed for active immunization of adult rabbits can produce a passive antibody immunity against RHDV-2 in rabbit kits without implementing a tailor-made administration program. Moreover, the produced immunity is likely to cover the early life of rabbits at least until they turn suitable to be vaccinated (older than 30 days of life).
Unduh artikel ini
Produk terkait
Vaksin rekombinan untuk melawan penyakit hemoragik kelinci (rabbit haemorrhagic disease - RHD) yang disebabkan oleh strain klasik (RHDV) dan variannya (RHDV2), termasuk strain yang sangat virulen, dalam bentuk emulsi untuk injeksi.
Vaksin inaktif terhadap varian baru RHDV-2 penyakit hemoragik kelinci, dalam emulsi injeksi
Inactivated vaccine against rabbit haemorrhagic disease RHDV-2 new variant, in injectable emulsion
Vaksin heterologous adjuvanted hidup untuk myxomatosis, dalam tablet kering-beku injeksi
Vaksin homologous hidup untuk myxomatosis, dalam tablet kering-beku injeksi
Vaksin mati untuk penyakit hemoragik, dalam emulsi injeksi
Enrofloxacin, dalam larutan oral
Layanan terkait
HIPRA University menawarkan program pelatihan berkualitas tinggi di bidang kepentingan strategis bagi profesional
Akses layanan diagnostik canggih dengan kenyamanan dan keandalan maksimum
